BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1279283)

  • 1. Release of multiple endothelium-derived relaxing factors from porcine coronary arteries.
    Myers PR; Guerra R; Harrison DG
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):392-400. PubMed ID: 1279283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
    Crack P; Cocks T
    Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
    Stork AP; Cocks TM
    Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.
    Boulanger C; Schini VB; Moncada S; Vanhoutte PM
    Br J Pharmacol; 1990 Sep; 101(1):152-6. PubMed ID: 2178013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery.
    Illiano S; Nagao T; Vanhoutte PM
    Br J Pharmacol; 1992 Oct; 107(2):387-92. PubMed ID: 1358391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of endothelium-dependent relaxations resistant to nitro-L-arginine in the porcine coronary artery.
    Nagao T; Vanhoutte PM
    Br J Pharmacol; 1992 Dec; 107(4):1102-7. PubMed ID: 1467832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin-induced, N omega-nitro-L-arginine-insensitive endothelium-dependent relaxation of porcine coronary arteries is not mediated by bioassayable relaxing substances.
    Kauser K; Rubanyi GM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S101-4. PubMed ID: 1282939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries.
    Holzmann S; Kukovetz WR; Windischhofer W; Paschke E; Graier WF
    J Cardiovasc Pharmacol; 1994 May; 23(5):747-56. PubMed ID: 7521457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol myristate acetate inhibits the bradykinin-induced L-nitro-arginine insensitive endothelium-dependent relaxation of bovine coronary artery.
    Obi T; Suzuki F; Nishio A
    Jpn J Pharmacol; 1993 Nov; 63(3):391-7. PubMed ID: 8107331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.
    Johns RA; Peach MJ; Linden J; Tichotsky A
    Circ Res; 1990 Oct; 67(4):979-85. PubMed ID: 2170053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery.
    Kühberger E; Groschner K; Kukovetz WR; Brunner F
    Br J Pharmacol; 1994 Dec; 113(4):1289-94. PubMed ID: 7889285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery.
    Kilpatrick EV; Cocks TM
    Br J Pharmacol; 1994 Jun; 112(2):557-65. PubMed ID: 7521260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide release from porcine mitral valves.
    Siney L; Lewis MJ
    Cardiovasc Res; 1993 Sep; 27(9):1657-61. PubMed ID: 7506994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise.
    Archer SL; Hampl V
    Biochem Biophys Res Commun; 1992 Oct; 188(2):590-6. PubMed ID: 1445303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
    Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nitro-L-arginine on endothelium-dependent hyperpolarizations and relaxations of pig coronary arteries.
    Pacicca C; von der Weid PY; Beny JL
    J Physiol; 1992 Nov; 457():247-56. PubMed ID: 1284311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple pathways underlying endothelium-dependent relaxation in the rabbit isolated femoral artery.
    Plane F; Pearson T; Garland CJ
    Br J Pharmacol; 1995 May; 115(1):31-8. PubMed ID: 7647981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of different relaxing factors by cultured porcine endothelial cells.
    Boulanger C; Hendrickson H; Lorenz RR; Vanhoutte PM
    Circ Res; 1989 Jun; 64(6):1070-8. PubMed ID: 2498003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise training improves endothelium-mediated vasorelaxation after chronic coronary occlusion.
    Griffin KL; Laughlin MH; Parker JL
    J Appl Physiol (1985); 1999 Nov; 87(5):1948-56. PubMed ID: 10562641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The basal and stimulated release of the endothelium-derived relaxing factor from isolated pig coronary arteries does not interfere with the vascular release of superoxide.
    Brandes RP; Dwenger A; Mügge A
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):183-7. PubMed ID: 7513382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.